Startup · $6.1m raised
Sydney, NSW
Every investor coverage indicates participated in a round Psylo raised.
| Investor | Rounds | Invested |
|---|---|---|
| Airtree’s Daniel Petre | Unnamed stage | - |
| CaraMed Capital | Seed | - |
| Daniel Petre | Unnamed stage | - |
| Empath Ventures | Seed | - |
| Lionheart Ventures | Seed | - |
| Main Sequence Ventures | Seed | - |
| Negev Capital | Seed | - |
| Possible Ventures | Unnamed stage | - |
| Startmate | Accelerator | - |
| UNSW Founders | Accelerator | - |
Companies Psylo acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Dr Sam Banister | Chief Scientific Officer | SmartCompany |
| Dr Samuel Banister | Chief Scientific Officer | Startup Daily (Tue 4 Jun 2024), Startup Daily (Thu 27 Oct 2022), Startup Daily (Wed 6 Oct 2021), Startup Daily (Fri 1 Oct 2021) |
| Josh Ismin | CEO · Founder | SmartCompany |
| Joshua Ismin | CEO | Startup Daily (Tue 4 Jun 2024), Startup Daily (Wed 6 Oct 2021), Startup Daily (Fri 1 Oct 2021) |
Stories naming Psylo. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Psylo, a Sydney maker of psychedelic therapies, has landed a US$8 million seed round led by Tenmile while moving to the US; earlier raises in 2022 and 2021 are recalled.
Biotech Aravax has received a US$20 million Series B commitment from Brandon Capital and Tenmile to advance its peanut allergy therapy PVX108 into Phase 2 trials.
Also Brandon Capital portfolio·Startup Daily·Startup News (WA)·Techboard·Startup Daily
UNSW Founders honoured eight winners at its inaugural awards, with Forage taking Startup of the Year; the piece also notes Psylo's $5 million seed raise and this year's 10x Demo Day cohort.
Sydney psychedelic biotech Psylo has banked a $5 million seed round led by CSIRO's Main Sequence Ventures, its second raise since emerging from Startmate, to advance a fast-acting psilocybin therapy toward clinical trials.
Giant Leap's impact newsletter rounds up CO2-eating microbes, precision fermentation, booming health tech funding, a women-in-work survey, its open Analyst role, Glow Capital's launch, Snow Entrepreneurs grants and Investible's climate tech fund.
Startup Daily lists the 19 Australian and New Zealand startups in Startmate's largest-ever Winter21 cohort pitching at Demo Day, including a climate stream backed by Mike Cannon-Brookes through Grok Ventures.
Sydney psychedelic biotech Psylo has raised $1.1 million in a round led by Possible Ventures, with angel Daniel Petre also backing it, to develop shorter-acting psilocybin-inspired mental health medicines.